Literature DB >> 1527017

Purification and characterization of a 50-kDa cysteine proteinase (gingipain) from Porphyromonas gingivalis.

Z Chen1, J Potempa, A Polanowski, M Wikstrom, J Travis.   

Abstract

Porphyromonas gingivalis, a Gram-negative anaerobic rod, has been closely associated with the initiation and progression of periodontal disease. This organism has been shown to produce a large number of proteolytic enzymes which can degrade a variety of tissue proteins, and these are considered to be major virulence factors. One of the proteinases produced by this organism, referred to as gingipain-1, has been purified to homogeneity from P. gingivalis culture medium by a combination of gel filtration and ion-exchange chromatography. The enzyme was found to have a molecular mass near 50 kDa by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, a pH optimum in the neutral to alkaline range, and a requirement for cysteine for activation and Ca2+ for stabilization. Amino-terminal sequence analysis indicated that gingipain belongs to a new, so far unknown, subfamily of cysteine proteinases. Three unusual features of this proteinase are: (a) the stimulation of amidolytic activity by glycine-containing dipeptides; (b) a narrow specificity which is limited to peptide bonds containing arginine residues; and (c) resistance to inhibition by proteinase inhibitors in human plasma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1527017

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  Inhibition of distant caspase homologues by natural caspase inhibitors.

Authors:  S J Snipas; H R Stennicke; S Riedl; J Potempa; J Travis; A J Barrett; G S Salvesen
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

2.  Mechanisms mediating Porphyromonas gingivalis gingipain RgpA-induced oral mucosa inflammation in vivo.

Authors:  I Rubinstein; J Potempa; J Travis; X P Gao
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

3.  Highly specific protease-based approach for detection of porphyromonas gingivalis in diagnosis of periodontitis.

Authors:  Wendy E Kaman; Fabiano Galassi; Johannes J de Soet; Sergio Bizzarro; Bruno G Loos; Enno C I Veerman; Alex van Belkum; John P Hays; Floris J Bikker
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

4.  Calcium-dependent activation and autolysis of Arabidopsis metacaspase 2d.

Authors:  Naohide Watanabe; Eric Lam
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

5.  Role of Porphyromonas gingivalis protease activity in colonization of oral surfaces.

Authors:  M Tokuda; M Duncan; M I Cho; H K Kuramitsu
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

6.  Characterization, genetic analysis, and expression of a protease antigen (PrpRI) of Porphyromonas gingivalis W50.

Authors:  J Aduse-Opoku; J Muir; J M Slaney; M Rangarajan; M A Curtis
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

7.  Effect of free and vesicle-bound cysteine proteinases of Porphyromonas gingivalis on plasma clot formation: implications for bleeding tendency at periodontitis sites.

Authors:  T Imamura; J Potempa; R N Pike; J N Moore; M H Barton; J Travis
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

8.  Cathepsin B in gingival crevicular fluid of adult periodontitis patients: identification by immunological and enzymological methods.

Authors:  E Ichimaru; M Tanoue; M Tani; Y Tani; T Kaneko; Y Iwasaki; K Kunimatsu; I Kato
Journal:  Inflamm Res       Date:  1996-06       Impact factor: 4.575

9.  Arginine deiminase inhibits Porphyromonas gingivalis surface attachment.

Authors:  Carla Cugini; Danielle N Stephens; Daniel Nguyen; Alpdogan Kantarci; Mary E Davey
Journal:  Microbiology       Date:  2012-12-14       Impact factor: 2.777

10.  Cysteine protease of Porphyromonas gingivalis 381 enhances binding of fimbriae to cultured human fibroblasts and matrix proteins.

Authors:  M Kontani; H Ono; H Shibata; Y Okamura; T Tanaka; T Fujiwara; S Kimura; S Hamada
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.